LENZ Therapeutics, Inc. (LENZ)
3.79
+0.20
(+5.57%)
USD |
NASDAQ |
Oct 06, 16:00
3.71
-0.08
(-2.11%)
After-Hours: 06:30
LENZ Therapeutics Gross Profit Margin (Quarterly) : 94.90% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 94.90% |
| March 31, 2026 | 37.56% |
| December 31, 2025 | 66.94% |
| Date | Value |
|---|---|
| September 30, 2025 | 99.00% |
| June 30, 2025 | 99.62% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Impact BioMedical, Inc. | -9.40K% |
| Enveric Biosciences, Inc. | -- |
| Liquidia Corp. | 93.10% |
| Aquestive Therapeutics, Inc. | 70.93% |
| ANI Pharmaceuticals, Inc. | 54.97% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.77% |
| Return on Assets | -50.68% |
| Return on Invested Capital | -54.57% |
| Profit Margin (Quarterly) | -581.8% |
| Operating Margin (Quarterly) | -622.9% |
| Return on Net Operating Assets | -2.11K% |